{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hastings",
      "state": "NE",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "85081",
      "recalling_firm": "Redline Pharmacy Solutions",
      "address_1": "2415 Osborne Dr E Ste 100",
      "address_2": "",
      "postal_code": "68901-1999",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Sold to patients in Nebraska",
      "recall_number": "D-1009-2020",
      "product_description": "Ertapenem in 100ML 0.9% NACL 1GM Injectable,  Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901",
      "product_quantity": "8 doses",
      "reason_for_recall": "Lack Of Processing Controls",
      "recall_initiation_date": "20200224",
      "center_classification_date": "20200312",
      "termination_date": "20220331",
      "report_date": "20200318",
      "code_info": "Lot 02242020@7",
      "more_code_info": ""
    }
  ]
}